Clinical Trial Update: Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug [Phase 1]

View source ↗

Summary

Phase 1 study of Mycamine in children to evaluate safety and drug blood levels in fungal infections; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis
• Oropharyngeal Candidiasis

Drugs mentioned

• Mycamine (Micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Oropharyngeal Candidiasis, Candidemia | Phase 1 | Status: COMPLETED